Pamela Gordon
Cardiovascular Disease · Wailuku, HINPI 1881629186
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 92 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 18 manufacturers, the largest accounting for just 22.9% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,678 and has fallen 91.2% since, to $147 in 2025.
Across 92 payments — averaging $35.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$755
- Boston Scientific$726
- Johnson & Johnson$659
- Janssen Scientific Affairs, LLC$209
- Inspire Medical Systems, Inc.$147
- Edwards Lifesciences$118
- plus $685 from 12 others
What the payments were for
- Food & beverage$3,299100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 18 | $755 |
| Boston Scientific | 17 | $726 |
| Johnson & Johnson | 31 | $659 |
| Janssen Scientific Affairs, LLC | 2 | $209 |
| Inspire Medical Systems, Inc. | 2 | $147 |
| Edwards Lifesciences | 1 | $118 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $117 |
| Irhythm Technologies, Inc. | 3 | $105 |
| Lantheus Medical Imaging, Inc. | 2 | $93 |
| Amgen | 5 | $91 |
| Abbott | 2 | $87 |
| Terumo Medical Corporation | 2 | $41 |
| Philips North America LLC | 1 | $37 |
| Stryker | 1 | $26 |
| Teleflex LLC | 1 | $25 |
| Bard Peripheral Vascular, Inc. | 1 | $24 |
| Gilead | 1 | $20 |
| Novartis | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- XARELTO$250
- Inspire$145
- RESONATE$144
- Micra$127
- Reveal LINQ$125
- Advisa$118
- Edwards SAPIEN 3 Transcatheter Heart Valve$118
- LifeVest$117
How this compares
$3,299 in reported general payments places this provider in the 60th percentile of 73 cardiovascular disease providers in Hawaii.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XareltoRivaroxaban | 35 | $42,186 |
| Metoprolol Succinate | 27 | $302 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $659 | $42,18635 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 73 cardiovascular disease providers in Hawaii.
Other cardiovascular disease in Wailuku
- Anil PunjabiWailuku$3K
- Amanda MarnWailuku$2K
- Wazhma AslamyWailuku$2K
- Kimble PoonWailuku$2K
- Howard BarbaroshWailuku$2K
- Michael RutledgeWailuku$997
- Jay ParikhWailuku$861
- Dipanjan BanerjeeHonolulu$331K
- Ryan SmithKaneohe$125K
- Ramy BadawiKailua$78K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.